Related Experiment Video
Updated: May 1, 2026

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation
Published on: July 5, 2024
[Predictors of efficacy of biofeedback therapy in patients with chronic constipation]
Miaomiao Li1, Bixing Ye1, Yurong Tang1
1Department of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Objective:
To explore the anorectal physiology, psychological state, quality of life, lifestyle of patients with chronic constipation (CC) and evaluate the factors which potentially predict the efficacy of biofeedback therapy (BF).
Methods:
Seventy CC patients receiving BF training were enrolled in this study. Anorectal physiology, Zung's Self-Rating Depression Scale (SDS), Zung's Self-Rating Anxiety Scale (SAS) and Chinese version of the MOS 36-item short form healthy survey (SF-36), lifestyle scale were recorded before BF training. A bowel symptom measurement including five major symptoms was recorded before and after BF training. The improvement in the symptom score was considered as criteria of clinical efficacy of BF therapy. Thirty-two possible influencing factors of efficacy of BF therapy were selected. Univariate analysis and multivariate analysis were conducted to assess the independent predictors.
Results:
The results of univariate analysis showed that efficacy of BF therapy was positively correlated to the role physical (r = 0.256, P = 0.031), negatively correlated to the score of SDS (r = -0.315, P = 0.007) and the first sensation threshold (r = -0.278, P = 0.020). The multivariate analysis showed the score of SDS (β = -0.263, P = 0.033) and the first sensation volume (β = -0.281, P = 0.013) were the independent predicator of efficacy of BF therapy.
Conclusion:
CC patients who tended to depression state and rectal hyposensitivity have poor response to BF therapy. To treat these patients purposely could optimize the efficacy of BF therapy.
More Related Videos
03:50Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
Published on: August 18, 2023
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Irritable Bowel Syndrome III: Medical and Nursing Management
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...